Protagonist Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$86(as of Oct 10, 4:38 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Protagonist Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$86

Ticker SymbolPTGX

ExchangeNasdaq

SectorHealthcare

IndustryBiotechnology

Employees130

CountyUSA

Market Cap$5,412.4M

EBIDTA24.9M

10-Day Moving Average67.43

P/E Ratio106.18

20-Day Moving Average65.13

Forward P/E Ratio26.39

50-Day Moving Average59.97

Earnings per Share0.73

200-Day Moving Average49.53

Profit Margin-626.96%

RSI83.43

Shares Outstanding62.2M

ATR4.22

52-Week High93.25

Volume7,065,291

52-Week Low33.31

Most Recent Support Level62.24

Book Value668.0M

Most Recent Resistance Level66.87

Upper Keltner74.62

Lower Keltner55.63

Debt-to-Equity Ratio74.62

Next Earnings Date11/05/2025

Cash Surplus133.0M

Next Ex-Dividend DateUnknown

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Protagonist Therapeutics Inc In Our Stock Scanner

As of Oct 13, 2025

example chart graphic

Scan Name: 52-Week HighScan Type: Stock Fundamentals

As of ---

example chart graphic

Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals

As of ---

example chart graphic

Scan Name: Momentum StocksScan Type: Stock Indicator Scans

As of ---

example chart graphic

Scan Name: Most Volatile StocksScan Type: Stock Indicator Scans

As of ---

example chart graphic

Scan Name: Unusual VolumeScan Type: Stock Indicator Scans

As of ---

example chart graphic

Scan Name: Uptrending StocksScan Type: Chart Pattern Scans

As of ---

example chart graphic

Scan Name: Cash SurplusScan Type: Stock Fundamentals

As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.